Real world study: A look at BMS' China Sprycel registry
This article was originally published in Scrip
Executive Summary
When staff at Bristol-Myers Squibb China did a search on clinicaltrials.gov for observational studies for adult chronic myeloma leukemia (CML) conducted in China, what they found was puzzling – there were zero results.